455 results on '"Grever M"'
Search Results
2. P655: RACIAL AND SOCIOECONOMIC DISPARITIES AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN THE US: ANALYSIS OF SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM DATA
3. Development of a distributed international patient data registry for hairy cell leukemia
4. Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
5. Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia
6. Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response
7. Cell line-based screening for new anticancer drugs
8. Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity
9. Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center
10. Phase I study of 5-aza-2′-deoxycytidine in combination with valproic acid in non-small-cell lung cancer
11. The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells
12. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
13. Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study
14. Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol
15. A Phase I Clinical and Pharmacokinetic Study of Fenretinide Combined with Paclitaxel and Cisplatin for Refractory Solid Tumors
16. Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia
17. The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells
18. Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells
19. Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features
20. Addressing food loss and waste in fish value chain using a web-based information, Repository
21. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies
22. 19. New Agents: 096 FLAVOPIRIDOL GIVEN AS A 30-MIN INTRAVENOUS (IV) BOLUS FOLLOWED BY 4-HR CONTINUOUS IV INFUSION (CIVI) RESULTS IN CLINICAL ACTIVITY AND TUMOR LYSIS IN REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
23. Phase-I study of oxaliplatin (NSC266046) and paclitaxel in advanced solid tumors: 638
24. Phase Ib study of heat shock protein 90 inhibitor, onalespib in combination with paclitaxel in patients with advanced, triple negative breast cancer (NCT02474173)
25. PS1149 SECOND CANCER INCIDENCE IN CLL PATIENTS RECEIVING BTK INHIBITORS
26. SECOND CANCER INCIDENCE IN CLL PATIENTS RECEIVING BTK INHIBITORS
27. Historical Consciousness: Conceptualizations and Educational Applications
28. Historical Consciousness: Conceptualizations and Educational Applications
29. Echoing National Narratives in English History Textbooks
30. National Narratives and the Invention of Ethnic Identities. Rethinking Cultural Memory and the Decolonised State
31. Historical Culture: A Concept Revisited
32. The appeal of heritage in education: Introduction
33. Archaeological Heritage Education and the Making of Regional Identities
34. Dutch Dealings with the Slavery Past; Contexts of an exhibition
35. Tagging Borobudur: Heritage Education and the Colonial Past in Onsite and Online Museum Collections
36. Introduction: the Appeal of Heritage Education
37. An intriguing historical trace or heritage? Learning about another person’s heritage in an exhibition addressing WWII
38. Introduction: the Appeal of Heritage Education
39. 350P - Phase Ib study of heat shock protein 90 inhibitor, onalespib in combination with paclitaxel in patients with advanced, triple negative breast cancer (NCT02474173)
40. Verlangen naar tastbaar verleden. Erfgoed, onderwijs en historisch besef
41. THE INTERNATIONAL PROGNOSTIC INDEX FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI)-AN INTERNATIONAL META-ANALYSIS
42. Wikipedia: Een virtuele graadmeter voor de maatschappelijke rol van geschiedenis?
43. De rechte lijn en de lus. Heideggers onderzoek naar de tijd en de geschiedenis van het tijdsbegrip
44. Aperte leugen
45. Vertogen van gelijkheid en uitsluiting: islam in Nederland
46. Denken over 'ras'. De ambivalente zoektocht naar antropologische helden
47. 'Vertogen over gelijkheid, religie en ras in de discussie over gelijkberechtiging van joden in Frankrijk en Nederland'
48. Van divers naar gelijk? Religie en politiek in het Midden-Oosten
49. Waar blijft de kritiek? Canon tussen wetenschap, politiek en cultuur
50. Levinas in Hollywood: Wat de film bijdroeg aan het idee van één menselijke soort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.